This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GIWERCMAN, A. Articles by SKAKKEBÆK, N. E. Search for Related Content PubMed PubMed Citation Articles by GIWERCMAN, A. Articles by SKAKKEBÆK, N. E.

Localized Irradiation of Testes with Carcinoma in Situ: Effects on Leydig Cell Function and Eradication of Malignant Germ Cells in 20 Patients^*

University Department of Growth and Reproduction Rigshospitalet
The Department of Oncology Rigshospitalet
The Department of Oncology-, Herleu University Hospital, University of Copenhagen (A.B.) Copenhagen
The Statistical Research Unit, University of Copenhagen Copenhagen
The Department of Gynecology and Obstetrics, Hillerfd Hospital Hillerfid, Denmark

Address all correspondence and requests for reprints to: Aleksander Giwercman, M.D., University Department of Growth and Reproduction, Rigshospitalet, Section 5064, 9 Blegdamsvej, DK 2100 Copenhagen, Denmark.

Twenty men (median age, 31 yr) previously treated for unilateral testicular cancer received localized irradiation in a dose of 20 Gray in 10 fractions for carcinoma in situ of the remaining testis. Follow-up testicular biopsies performed 3 (n = 19) and 24 (n = 14) months after the treatment showed in all cases a Sertoli cell-only pattern. Hormonal evaluation was performed before as well as 3, 12, 24, and 36 months after radiation treatment. Endocrine parameters were followed for a median of 30 months (3–36 months). Baseline serum testosterone values decreased during the follow-up period from 13.3 ± 6.0 to 10.8 ± 6.4 nmol/L (mean ± SD), although the decrease was not statistically significant (P = 0.06). Serum LH values increased during the first 3 months of follow-up from 10.4 ± 5.4 to 15.6 ± 7.3 IU/L (P < 0.0001) and then remained unchanged. Significant decreases in GnRH- and hCG-stimulated testosterone levels also indicated an impairment of Leydig cell function. FSH levels increased (P < 0.0001) during the first 3 months of follow-up from 21.8 ± 11.1 to 33.2 ± 13.2 IU/L. We conclude that localized irradiation of 20 Gray eradicated carcinoma in situ germ cells. Development of a second testicular cancer has until now been prevented. Leydig cell function was partially impaired by the radiation dose given.

^* This work was supported by grants from the Danish Cancer Society (Grants 88–100,89–027, 90–072, 90–090,91–032, and 74–9/89) and the Daell Foundation.

Received September 10, 1990.

This article has been cited by other articles:

				P. M. Petersen, A. Giwercman, G. Daugaard, M. Rorth, J. H. Petersen, N. E. Skakkebaek, S. W. Hansen, and H. von der Maase Effect of Graded Testicular Doses of Radiotherapy in Patients Treated for Carcinoma-In-Situ in the Testis J. Clin. Oncol., March 15, 2002; 20(6): 1537 - 1543. [Abstract] [Full Text] [PDF]

				P. M. Petersen, A. Giwercman, S. W. Hansen, J. G. Berthelsen, G. Daugaard, M. Rorth, and N. E. Skakkebak Impaired Testicular Function in Patients With Carcinoma-In-Situ of the Testis J. Clin. Oncol., January 1, 1999; 17(1): 173 - 173. [Abstract] [Full Text] [PDF]

				P. M. Petersen, A.-M. Andersson, M. Rørth, G. Daugaard, and N. E. Skakkebæk Undetectable Inhibin B Serum Levels in Men after Testicular Irradiation J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 213 - 215. [Abstract] [Full Text]

				H. Roelofs, R. J. H. L. M. van Gurp, J. W. Oosterhuis, and L. H. J. Looijenga Detection of Human Endogenous Retrovirus Type K-Specific Transcripts in Testicular Parenchyma and Testicular Germ Cell Tumors of Adolescents and Adults : Clinical and Biological Implications Am. J. Pathol., October 1, 1998; 153(4): 1277 - 1282. [Abstract] [Full Text] [PDF]

				S.-C. J. Yeung, A. C. Chiu, R. Vassilopoulou-Sellin, and R. F. Gagel The Endocrine Effects of Nonhormonal Antineoplastic Therapy Endocr. Rev., April 1, 1998; 19(2): 144 - 172. [Abstract] [Full Text]